Proteon Pharmaceuticals specializes in innovative bacteriophage technology aimed at enhancing animal health and promoting sustainable practices in livestock farming and aquaculture. Their approach leverages the natural ability of bacteriophages—viruses that specifically target and eliminate harmful bacteria—to address critical challenges such as antimicrobial resistance (AMR) and food safety. By utilizing bacteriophage-based feed additives, Proteon aims to improve gut health in poultry, which is essential for productivity and overall animal well-being. Their products, such as BAFASAL® and BAFACOL®, are designed to prevent infections from pathogens like Salmonella and Avian Pathogenic E. coli, thereby reducing the reliance on antibiotics and contributing to healthier livestock.

In addition to poultry, Proteon’s bacteriophage solutions extend to aquaculture, where they focus on preventing bacterial infections in fish, particularly those caused by Pseudomonas and Aeromonas species. The company emphasizes the economic benefits of their products, which not only enhance animal health but also improve food safety and quality. By ensuring that their bacteriophage products are safe, non-toxic, and biodegradable, Proteon Pharmaceuticals positions itself as a leader in sustainable agricultural practices, ultimately aiming to meet the growing global demand for antibiotic-free and environmentally responsible protein production.

Poland

Proteon Pharmaceuticals S.A. uses precision biology for microbiome modulation to improve animal and human health, increasing environmental sustainability and eliminating the unnecessary use of antibiotics.

PROTEON's products improve the economic efficiency in livestock farming and aquaculture, increasing environmental sustainability with natural products that also enhance animal welfare.

Proteon Pharmaceuticals

Company Details